“Tardive Dyskinesia: How to prevent and treat a lingering nemesis” (Current Psychiatry, October 2003) was a very good, basic article. The algorithm on managing tardive dyskinesia was particularly helpful, and the information on possible reversible dyskinesias with mood stabilizers and with antihistamines such as Benadryl was a useful refresher.
For MDs such as I who practice in rural clinics, however, more-specific dosage information would be useful—even for experimental agents such as tetrabenazine—since we do not have ready access to higher-level movement disorder clinics. The nearest such clinic to my practice is 2 1/2 hours away, an impossible commute for many of my patients.
Sophia Bezirganian MD
Trumansburg, NY